66. IgA nephropathy Clinical trials / Disease details

Clinical trials : 255 / Drugs : 255 - (DrugBank : 79) / Drug target genes : 35 - Drug target pathways : 137

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00396721 (ClinicalTrials.gov)	January 2006	3/11/2006	Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy	Pilot Trial of Treatment of Poor-Prognosis IgA Nephropathy With Low Exposure to Sirolimus.	Glomerulonephritis, IGA;Nephropathy, IGA;IGA Nephropathy	Drug: ACE inhibitor + statin;Drug: Sirolimus (study drug)+ACE inhibitor + statin	Josep m Cruzado	Wyeth is now a wholly owned subsidiary of Pfizer	Completed	18 Years	70 Years	Both	23	Phase 2	Spain
2	EUCTR2005-002610-37-ES (EUCTR)	05/12/2005	30/09/2005	PILOT TRIAL OF TREATMENT OF POOR-PROGNOSIS IgA NEPHROPATHY WITH LOW EXPOSURE TO SIROLIMUS.Ensayo clí ...	PILOT TRIAL OF TREATMENT OF POOR-PROGNOSIS IgA NEPHROPATHY WITH LOW EXPOSURE TO SIROLIMUS.Ensayo clí ...	To test in a pilot trial the efficacy and tolerance of sirolimusoral (at low doses) in patient to tr ...	Trade Name: RAPAMUNE Product Name: SIROLIMUS INN or Proposed INN: Sirolimus Trade Name: RAPAMUNE Product ...	NEPHROLOGY DEPARTMENT (HOSPITAL UNIVERSITARY OF BELLVITGE)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30		Spain

First Previous1Next Last